Cronos Group Inc. (CRON)
NASDAQ: CRON · Real-Time Price · USD
2.010
-0.020 (-0.99%)
At close: Nov 20, 2024, 4:00 PM
2.020
+0.010 (0.50%)
Pre-market: Nov 21, 2024, 7:10 AM EST
Cronos Group Market Cap
Cronos Group has a market cap or net worth of $761.60 million as of November 21, 2024. Its market cap has increased by 5.18% in one year.
Market Cap
761.60M
Enterprise Value
-20.17M
1-Year Change
5.18%
Ranking
Category
Stock Price
$2.01
Market Cap Chart
Since February 27, 2018, Cronos Group's market cap has decreased from $1.14B to $761.60M, a decrease of -33.08%. That is a compound annual growth rate of -5.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 776.10M | -2.56% |
| Dec 29, 2023 | 796.50M | -17.14% |
| Dec 30, 2022 | 961.30M | -34.04% |
| Dec 31, 2021 | 1.46B | -41.04% |
| Dec 31, 2020 | 2.47B | -6.25% |
| Dec 31, 2019 | 2.64B | 42.01% |
| Dec 31, 2018 | 1.86B | 63.14% |
| Feb 27, 2018 | 1.14B | - |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rapport Therapeutics | 782.19M |
| Avid Bioservices | 782.18M |
| AbCellera Biologics | 781.24M |
| Erasca | 780.33M |
| Castle Biosciences | 777.06M |
| Cytek Biosciences | 774.80M |
| Avanos Medical | 771.29M |
| Pacira BioSciences | 768.78M |